As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1
Lincoff AM , 2023, Semaglutide and cardiovascular outcomes in obesity without diabetes, N Engl J Med 389 24 8
Stage two is that the members turn up at the session and their heart rate tracking technologies pop-up on the screens via the brand's LionHeart heart strap monitor as soon as they walk in
its to fuel your body correctly while the medication does its job
In SURMOUNT-1, adults with obesity (without diabetes) lost an average of 15.0%, 19.5%, and 20.9% of body weight with tirzepatide 5 mg, 10 mg, and 15 mg respectively over 72 weeks, compared to 3.1% with placebo
Our products are verified by independent third party laboratories to meet quality standards